Therefore, researchers are striving to develop alternative strategies to treat ADRP, particularly rhodopsin-associated RP, which accounts for over 25% of all ADRP cases (Dryja et al., 1991; Sullivan et al., 2013). This evidence concerns the gene PLIN2 and retinitis pigmentosa 1.